Citation Formats
Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

G. ÖZYİĞİT Et Al. , "Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer," WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, pp.283-292, 2019

ÖZYİĞİT, G. Et Al. 2019. Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8 , 283-292.

ÖZYİĞİT, G., HÜRMÜZ, P., YÜCE, D., & Akyol, F., (2019). Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, 283-292.

ÖZYİĞİT, GÖKHAN Et Al. "Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer," WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, 283-292, 2019

ÖZYİĞİT, GÖKHAN Et Al. "Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer." WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, pp.283-292, 2019

ÖZYİĞİT, G. Et Al. (2019) . "Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer." WORLD JOURNAL OF CLINICAL ONCOLOGY , vol.10, no.8, pp.283-292.

@article{article, author={GÖKHAN ÖZYİĞİT Et Al. }, title={Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer}, journal={WORLD JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={283-292} }